ImmuCell Corporation Accounts Receivable, Allowance for Credit Loss, Recovery
ImmuCell Corporation (ICCC) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2026-03-30
- ImmuCell Corporation accounts receivable, allowance for credit loss, recovery for the quarter ending 2025-12-31 was $0.00.
- ImmuCell Corporation accounts receivable, allowance for credit loss, recovery for the quarter ending 2025-09-30 was $0.00.
- ImmuCell Corporation accounts receivable, allowance for credit loss, recovery for the quarter ending 2024-12-31 was $0.00.
- ImmuCell Corporation accounts receivable, allowance for credit loss, recovery for the quarter ending 2024-09-30 was $0.00.
- ImmuCell Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2025 was $0.00.
- ImmuCell Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2024 was $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |